Oscar Health Inc. (OSCR) Tops Q3 EPS by 3c; offers guidance

Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.53), $0.03 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $2.99 billion versus the consensus estimate of $3.08 billion.

GUIDANCE:

Oscar Health Inc. sees FY2025 revenue of $12-12.2 billion, versus the consensus of $12.038 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Stripe, Advent In Talks To Buy Paypal - WSJ
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c